Intracoastal Capital Amends Palisade Bio Stake on Dec 31, 2023
Ticker: PALI · Form: SC 13G/A · Filed: Feb 6, 2024 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | SC 13G/A |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Intracoastal Capital updated its passive stake in Palisade Bio as of year-end 2023.**
AI Summary
Intracoastal Capital, LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed an amended Schedule 13G/A on February 6, 2024, indicating their ownership of Palisade Bio, Inc. common stock as of December 31, 2023. This amendment updates their previous filing, signaling a potential change in their passive investment stake in the company. For investors, this matters because significant changes in institutional ownership can influence stock perception and liquidity, especially for a smaller biotech company like Palisade Bio.
Why It Matters
This filing updates the public record on a significant investor's stake in Palisade Bio, which can impact investor sentiment and potentially signal future actions by this institutional holder.
Risk Assessment
Risk Level: low — This is a routine amendment to a passive ownership filing, indicating no immediate high-risk actions or significant changes in control.
Analyst Insight
Investors should note the continued presence of Intracoastal Capital as a significant holder, but this routine amendment doesn't suggest any immediate buy or sell action. It's a data point for tracking institutional interest.
Key Numbers
- 696389204 — CUSIP Number (identifies Palisade Bio, Inc. common stock)
- December 31, 2023 — Date of Event (the date as of which the ownership information is reported)
- February 6, 2024 — Filing Date (the date the amendment was filed with the SEC)
Key Players & Entities
- Intracoastal Capital, LLC (company) — reporting person and institutional investor
- Mitchell P. Kopin (person) — reporting person and group member
- Daniel B. Asher (person) — group member
- Palisade Bio, Inc. (company) — subject company whose stock is being reported
- $0.01 (dollar_amount) — par value per share of common stock
Forward-Looking Statements
- Intracoastal Capital will maintain a passive investment stance in Palisade Bio for the foreseeable future. (Intracoastal Capital, LLC) — medium confidence, target: Q4 2024
- Palisade Bio's stock price will not see significant immediate movement solely due to this routine filing. (Palisade Bio, Inc.) — high confidence, target: Q2 2024
FAQ
Who are the reporting persons in this SC 13G/A filing?
The reporting persons are Intracoastal Capital, LLC and Mitchell P. Kopin. Daniel B. Asher is also listed as a group member.
What is the subject company of this filing?
The subject company is Palisade Bio, Inc., identified by the CUSIP Number 696389204.
What type of security is being reported in this filing?
The security being reported is Common Stock, with a par value of $0.01 per share, of Palisade Bio, Inc.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), as indicated by the checked box on the cover page.
Filing Stats: 1,104 words · 4 min read · ~4 pages · Grade level 8.1 · Accepted 2024-02-06 10:29:39
Key Financial Figures
- $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of
Filing Documents
- ea192887-13ga2intra_palisade.htm (SC 13G/A) — 53KB
- 0001213900-24-010339.txt ( ) — 55KB
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ . Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 5 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 6, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 6 of 6